Skip to main content
Tech.euFundingExplorerBeta

Seqstant

LiveGene, a software “that makes it possible to quickly and comprehensively detect pathogens using sequencing with one click

Seqstant has raised €1.8M across 1 funding round from 5 investors, most recently a round in Nov 2023. Based in Teltow, Germany; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€1.8M
€1,800,000
Funding rounds
1
Investors
5
distinct backers
Active since
2023-11
latest 2023-11

Funding by year

EUR raised per year
Seqstant — funding by year — interactive chart.
Data table
Seqstant — funding by year
2023€1.8M

Signals

High confidence
Raise-next likelihood6
base rate 30% for Other
  • ▼ Past typical raise window
  • ▼ Low backer re-investment

Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 round
DateStageAmountInvestors
2023-11-20Other€1.8MAngel Investors,Brandenburg Kapital,HPI Seed Fund,Impact Partners,Venture LeagueView deal →

Similar companies

same sector or country

Global coverage: FundingData